2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Colorectal Cancer
In the realm of cancer research, colorectal cancer stands as a focal point due to its prevalence and impact. Scientists delve into various aspects, from genetic predispositions to environmental influences, seeking innovative strategies for prevention, early detection, and treatment. Advanced screening techniques, like colonoscopies and genetic testing, enable early intervention, potentially saving lives. Immunotherapies and targeted therapies offer promising avenues for personalized treatment, tailoring approaches based on individual genetic profiles. Moreover, researchers explore the microbiome's role, investigating how gut bacteria influence cancer development and treatment outcomes. Collaborative efforts across disciplines drive progress, aiming not only to combat colorectal cancer but also to enhance survivorship and quality of life for affected individuals. Through relentless exploration and innovation, the field of colorectal cancer research strives to pave the way towards better outcomes and ultimately, a world free from this disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China